DIALYSIS-DEPENDENT KIDNEY FAILURE

Clinical trials for DIALYSIS-DEPENDENT KIDNEY FAILURE explained in plain language.

Never miss a new study

Get alerted when new DIALYSIS-DEPENDENT KIDNEY FAILURE trials appear

Sign up with your email to follow new studies for DIALYSIS-DEPENDENT KIDNEY FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Global trial aims to shield fragile kidneys from deadly heart attacks

Disease control Ongoing

This large, late-stage trial is testing whether a low dose of the blood-thinning drug rivaroxaban can safely reduce the risk of heart attacks, strokes, and death in people with advanced or dialysis-dependent kidney disease. It will enroll 2,000 participants worldwide who have kid…

Matched conditions: DIALYSIS-DEPENDENT KIDNEY FAILURE

Phase: PHASE3 • Sponsor: The George Institute • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

DIALYSIS-DEPENDENT KIDNEY FAILURE

Get alerted when new DIALYSIS-DEPENDENT KIDNEY FAILURE trials appear

Global trial aims to shield fragile kidneys from deadly heart attacks